Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine

Benzer Materyaller

• Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
  Yazar:: Nygård, Mari, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries
  Yazar:: Kjaer, Susanne K., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Mother-Infant Transfer of Anti-Human Papillomavirus (HPV) Antibodies following Vaccination with the Quadrivalent HPV (Type 6/11/16/18) Virus-Like Particle Vaccine
  Yazar:: Matys, Katie, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.
  Yazar:: Mari Nygård, ve diğerleri
  Baskı/Yayın Bilgisi: (2014-01-01)
• Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance
  Yazar:: Nygård, Mari, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)